Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 14, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 352 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: National Institute of General Medical Sciences (NIGMS) Clear all

Conditions: Stroke, Sensorimotor Impairment
Interventions: Visuomotor learning task; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: ACL Tears
Interventions: Progressive strengthening program; Other
Lead sponsor: Creighton University; Other
Eligibility: 14 Years to 35 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Pilonidal Disease
Interventions: Laser hair depilation, Standard of Care (SOC); Procedure · Other
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 10 Years to 21 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Pain
Interventions: Active Virtual Reality, Passive Virtual Reality; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 8 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Critical Illness, Intensive Care, Intensive Care Unit
Interventions: Not listed
Lead sponsor: National Institute of General Medical Sciences (NIGMS); NIH
Eligibility: 18 Years and older
Enrollment: 6,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Adolescent Obesity, Diet, Weight Loss, Sleep
Interventions: Breakfast / Lunch, Dinner (DIN); Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 13 Years to 17 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Heart Failure, Heart Diseases, Cardiovascular Diseases, Endothelial Dysfunction
Interventions: Heat Therapy Treatment; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 50 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Sepsis, Trauma Injury
Interventions: Blood sampling; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 100 Years
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Mental Function
Interventions: Low-intensity focused ultrasound pulsation (LIFUP), Functional Magnetic Resonance Imaging (fMRI) using Propofol; Device · Combination Product
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 40 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Smoking, Asthma, Electronic Cigarette Use, Cigarette Smoking
Interventions: Nicotine; Other
Lead sponsor: Brown University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Sickle Cell Disease
Interventions: SCD-Omegatex™; Drug
Lead sponsor: Robin E. Miller; Other
Eligibility: 8 Years to 25 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Cardiac Arrest, Inflammation, Obesity, Hypoxic Ischemic Encephalopathy (HIE)
Interventions: Not listed
Lead sponsor: MaineHealth; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Portland, Maine

Conditions: Out-Of-Hospital Cardiac Arrest, Pneumonia
Interventions: Standard of care without prophylaxis, Antibiotic prophylaxis; Drug
Lead sponsor: David J. Gagnon; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Portland, Maine

Conditions: Septic Shock
Interventions: Levo-Carnitine, placebo; Drug
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 14
States / cities: Birmingham, Alabama • Sacramento, California • Wilmington, Delaware + 9 more

Conditions: ColoRectal Cancer
Interventions: Screening patient navigation, Non-Navigated; Behavioral
Lead sponsor: University of Nevada, Reno; Other
Eligibility: 50 Years to 85 Years
Enrollment: 415 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Reno, Nevada

Conditions: Phobias
Interventions: Placebos, Propofol 0.45mcg/mL, Propofol 0.90mcg/mL, Thiopental 1.5mcg/mL, Thiopental 3mcg/mL; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy Volunteer, Prostate Cancer, Head and Neck Cancer, Esophageal Cancer, Genitourinary Cancer, Sarcoma, Breast Cancer, Colon Cancer, Gastrointestinal Cancer, Solid Tumor Cancer, Lung Cancer, Skin Cancer, Melanoma
Interventions: Not listed
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Maternal Health, Infant Health, Hypertension, Behavioral Medicine, Mindfulness, Psychophysiology, Cardiovascular Diseases, Cardiovascular Diseases Risk
Interventions: Follow up to Mindfulness RCT using a Still Face Paradigm; Other
Lead sponsor: Lifespan; Other
Eligibility: 6 Months and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: All Malignancies, Children Being Treated for Catastrophic Illness
Interventions: Not listed
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Not listed
Enrollment: 8,800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2034
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Drug Use, Substance Abuse, Mental Illness
Interventions: Integrated Harm Reduction Intervention (IHRI); Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 3
States / cities: New Haven, Connecticut • New York, New York • Orangeburg, New York

Conditions: Healthy
Interventions: Placebo, Propofol, Thiopental; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Inflammation; Skin, Resolution, Blister
Interventions: Lovaza, Cantharone, Phlebotomy; Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 64 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Parkinson Disease, Healthy Aging
Interventions: Cognitive dual-task walking; Other
Lead sponsor: University of Nebraska; Other
Eligibility: 60 Years to 90 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Stress Hyperglycemia
Interventions: Dulaglutide Injection, Saline Injection; Drug · Other
Lead sponsor: Emory University; Other
Eligibility: 40 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 3
States / cities: Atlanta, Georgia

Search by objective public record fields.

Learning in Stroke

Characterizing Clinical and Biomechanical Contributions to Function Following ACL Reconstruction

Pilot Trial Assessing the Effectiveness of Laser Hair Depilation on Pilonidal Disease Recurrence in Patients With Darker Skin Color

Virtual Reality Water Friendly Wound Care

Critical Illness Outcomes Study

Chrononutrition and Adolescent Weight Control

Effects of Passive Heat Therapy on Oxygen Consumption and Cardiovascular Fitness in Adults

Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis

Ultrasonic Deep Brain Stimulation During Anesthetic Sedation

E-cigarettes for Harm Reduction in Adults With Asthma

Omega-3 Fatty Acids in Sickle Cell Disease

Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)

Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)

Rapid Administration of Carnitine in sEpsis

Community Engaged Colon Cancer Screening Patient Navigator Program

The Effect of Intravenous Anesthetics on Fear Learning and Memory

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Stress Reactivity and Mother-Infant Cardiovascular Disease Risk

Pharmacogenetic Determinants Of Treatment Response In Children

Harm Reduction Services

Neuroimaging the Effects of Intravenous Anesthetic on Amygdala Dependent Memory Processes

Pro-Resolving Mediators in Acute Inflammation in Humans

Longitudinal Analysis of Gait Variability to Predict Falls in Parkinson's Disease

Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients